What Happens When You Stop GLP-1 Injections?

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on peptides and GLP-1 pathways. Browse all Peptides & GLP-1 education

GLP-1 receptor agonists work while they are in your system — and their effects fade once they leave it. That single fact explains most of what happens when someone stops GLP-1 injections. Understanding the physiology ahead of time turns a surprising outcome into an expected one, and makes it easier to plan a next step with a licensed provider rather than reacting to it.

Why the Effects Depend on Continued Use

A GLP-1 receptor agonist like semaglutide keeps activating the GLP-1 receptor, which slows stomach emptying and signals fullness to the brain. Those signals are pharmacological, not permanent rewiring. When the medication clears, the receptor is no longer being stimulated by the drug, and the body's baseline appetite regulation returns — the same biology you had before starting.

Appetite and Hunger Return

The most immediate change most people notice is the return of appetite. Food no longer feels as filling as quickly, and the reduced "food noise" that many describe on GLP-1 therapy tends to come back. This is expected physiology, not a personal failure. The medication was doing the appetite-signaling work; without it, your innate hunger drivers resume their normal role.

What the Research Shows About Weight Regain

The clearest data come from a semaglutide withdrawal study. In the STEP 1 trial extension (Wilding and colleagues, 2022), participants who stopped semaglutide regained about two-thirds of the weight they had lost within roughly a year, and many cardiometabolic improvements moved back toward baseline. The researchers framed this as evidence that obesity behaves like a chronic condition requiring ongoing management, not a one-time fix. It is a physiological pattern, not a comment on willpower.

Stopping Is a Clinical Decision

How and when to stop — or whether to continue, pause, or change course — is a decision for a licensed healthcare provider, not something to self-manage. Abrupt self-adjustment can disrupt the plan a provider has built around your goals, other medications, and health history. This article intentionally gives no tapering schedule or dosing instructions, because those belong in a clinical conversation. The safe move is to raise the question with your provider before making any change.

The Genetic Variables: FTO and MC4R

Why appetite returns so forcefully for some people and more gently for others is partly genetic. Two genes sit at the center of appetite regulation. FTO, the fat mass and obesity-associated gene, carries a common variant (rs9939609) linked to higher BMI, increased hunger, and altered ghrelin signaling. MC4R, the melanocortin-4 receptor gene, is a master regulator of satiety in the hypothalamus; variants near it (such as rs17782313) are among the most reproducible genetic influences on body weight, and rare MC4R mutations are the most common single-gene cause of obesity.

These variants describe the baseline appetite biology that reasserts itself when a GLP-1 medication is stopped. They do not predict how any drug will perform — that is a boundary worth stating plainly. Pathway-level genetics maps your starting point, not the outcome of a protocol.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, dispensed through licensed 503A compounding pharmacies, with clinical oversight built in. What sets the PlexusDx approach apart is the upstream genetic context. Before starting — or reassessing — any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including variants in FTO and MC4R that shape your baseline appetite biology. Knowing that profile is the test-before-you-invest approach, turning guesswork into an informed conversation with your healthcare provider.

Frequently Asked Questions: Stopping GLP-1 Injections

What happens when you stop GLP-1 injections?

Appetite and hunger typically return within days to weeks as the medication clears and stops stimulating the GLP-1 receptor. In the STEP 1 extension study, participants regained about two-thirds of lost weight within a year of stopping semaglutide. This is expected physiology, not a personal failure.

Will I regain all the weight if I stop?

Not necessarily all of it, but research shows significant regain is common. The STEP 1 extension found roughly two-thirds returned within a year on average. Individual outcomes vary with genetics, lifestyle, and follow-up care. Discuss any change with your provider, who can plan around your specific situation.

Does genetic testing predict how I will respond after stopping?

No. The Precision Peptide Genetic Test does not predict medication response or regain. It analyzes pathway-level appetite variants such as those in FTO and MC4R that describe your baseline biology. That context informs a conversation with your provider — it does not forecast what happens when you stop a specific drug.

How should I stop taking a GLP-1 medication?

Only under the guidance of a licensed healthcare provider. Whether to stop, pause, or change course depends on your goals, other medications, and health history. This article gives no tapering or dosing instructions on purpose — those decisions belong in a clinical conversation, not a self-managed one.

Plan your next step with context: explore the PlexusDx Weight Management Protocols, and start upstream by taking the Precision Peptide Genetic Test to understand the FTO and MC4R appetite biology behind your results.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

This article is educational. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — this article covers the mechanism, evidence, and genetic context that informs any decision to use it. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.